Exploring the Pathogenesis of Spondylarthritis beyond HLA-B27: A Descriptive Review.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
31 May 2024
Historique:
received: 21 03 2024
revised: 15 05 2024
accepted: 29 05 2024
medline: 19 6 2024
pubmed: 19 6 2024
entrez: 19 6 2024
Statut: epublish

Résumé

Spondylarthritis (SpA) is a chronic inflammatory condition that encompasses damage to the axial or peripheral skeleton, accompanied by specific extra-articular symptoms. Within this group, Ankylosing Spondylitis stands out as the hallmark member. Although the heritability of Ankylosing Spondylitis is estimated to be over 95%, only a portion of the heritability has been explained, with HLA-B27 accounting for 20.1% of it; therefore, ongoing research endeavors are currently concentrated on investigating the potential participation of different entities in the development of the disease. Genome-wide association studies have led to significant advances in our understanding of the genetics of SpA. In this descriptive review, we delve into the pathogenesis of Spondylarthritis beyond HLA-B27. We summarize the latest research on the potential participation of various entities in the development of the disease, including other genetic loci, immune dysregulation, microbiota, and environmental factors. The multifactorial nature of SpA and the complex interplay of genetic, immunological, and environmental factors are being increasingly recognized; therefore, it is of paramount importance to consider a holistic approach to comprehend the pathogenesis of SpA in order to identify novel therapeutic targets.

Identifiants

pubmed: 38892265
pii: ijms25116081
doi: 10.3390/ijms25116081
pii:
doi:

Substances chimiques

HLA-B27 Antigen 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Ruxandra-Elena Nagit (RE)

Immunology Department, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania.

Elena Rezus (E)

Rheumatology Department, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania.
Clinical Rehabilitation Hospital, 700661 Iași, Romania.

Petru Cianga (P)

Immunology Department, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania.
Immunology Laboratory, "St. Spiridon" Clinical Hospital, 700111 Iași, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH